SILO PHARMA, INC. Repayments of Other Debt
SILO PHARMA, INC. (SILO) reported Repayments of Other Debt of $330.82 thousand for the 12-month period ending 2023-12-31, per its 10-Q filed 2024-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherDebt · last filed 2024-08-13
- SILO PHARMA, INC. repayments of other debt for the quarter ending 2023-03-31 was $430.82K.
| Period end | Repayments of Other Debt 3 month | Repayments of Other Debt 12 month |
|---|---|---|
| 2023-12-31 | $330.82K 10-Q · filed 2024-05-13 | |
| 2023-03-31 | $430.82K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |